ERS/ESICM/ESCMID/ALAT 重症社区获得性肺炎管理指南
该指南由欧洲呼吸学会(ERS)、欧洲重症医学会(ESICM)、欧洲临床微生物学和感染病学会(ESCMID)及拉丁美洲胸科协会(ALAT)联合制定,是首部针对重症社区获得性肺炎(sCAP)的国际指南。工作组由18名欧洲专家、4名非欧洲专家及2名方法学家组成,选定8个关于sCAP诊断和治疗的临床问题,进行系统文献检索,尽可能采用Meta分析合成证据,并使用GRADE评估证据质量,通过证据到决策框架确定推荐方向和强度。推荐内容涉及诊断、抗生素、器官支持、生物标志物和辅助治疗,并指出了当前知识空白和未来研究方向。
要点
- 指南由ERS、ESICM、ESCMID和ALAT联合制定,是首部针对sCAP的国际指南。
- 工作组包括18名欧洲专家、4名非欧洲专家和2名方法学家,选定8个sCAP诊断和治疗临床问题。
- 采用系统文献检索和Meta分析合成证据,使用GRADE评估证据质量,通过证据到决策框架形成推荐。
- 推荐内容涵盖诊断、抗生素、器官支持、生物标志物和辅助治疗。
- 指南指出了当前知识空白并提出了未来研究建议。
适用人群与场景
- 重症社区获得性肺炎(sCAP)患者。
研究设计与关键结果
- 该指南由ERS、ESICM、ESCMID和ALAT联合启动工作组制定,是首部sCAP国际指南。
- 工作组由18名欧洲专家、4名非欧洲专家和2名方法学家组成,选定8个关于sCAP诊断和治疗的临床问题。
- 系统文献检索在多个数据库中进行,尽可能采用Meta分析合成证据,使用GRADE评估证据质量,并通过证据到决策框架确定推荐方向和强度。
- 推荐涉及诊断、抗生素、器官支持、生物标志物和辅助治疗,在考虑效应估计置信度、结局重要性、治疗利弊、成本、可行性、可接受性及健康公平性影响后,做出支持或反对特定治疗干预的推荐。
证据类型、等级与局限
- 证据类型:国际指南;采用GRADE方法评估证据质量,并通过证据到决策框架形成推荐。
- 局限:原文未报告局限性
对床旁实践的改变
- 该指南为sCAP的诊断、经验性治疗和抗生素治疗提供基于证据的临床实践推荐,并指出当前知识空白和未来研究方向。
指南或共识出处
- ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia(ERS/ESICM/ESCMID/ALAT 重症社区获得性肺炎管理指南),发表于 Intensive Care Med。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
PURPOSE: Severe community-acquired pneumonia (sCAP) is associated with high morbidity and mortality, and whilst European and non-European guidelines are available for community-acquired pneumonia, there are no specific guidelines for sCAP.
METHODS: The European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID), and Latin American Thoracic Association (ALAT) launched a task force to develop the first international guidelines for sCAP. The panel comprised a total of 18 European and four non-European experts, as well as two methodologists. Eight clinical questions for sCAP diagnosis and treatment were chosen to be addressed. Systematic literature searches were performed in several databases. Meta-analyses were performed for evidence synthesis, whenever possible. The quality of evidence was assessed with GRADE (Grading of Recommendations, Assessment, Development and Evaluation). Evidence to Decision frameworks were used to decide on the direction and strength of recommendations.
RESULTS: Recommendations issued were related to diagnosis, antibiotics, organ support, biomarkers and co-adjuvant therapy. After considering the confidence in effect estimates, the importance of outcomes studied, desirable and undesirable consequences of treatment, cost, feasibility, acceptability of the intervention and implications to health equity, recommendations were made for or against specific treatment interventions.
CONCLUSIONS: In these international guidelines, ERS, ESICM, ESCMID, and ALAT provide evidence-based clinical practice recommendations for diagnosis, empirical treatment, and antibiotic therapy for sCAP, following the GRADE approach. Furthermore, current knowledge gaps have been highlighted and recommendations for future research have been made.
参考来源
- Martin-Loeches I, Torres A, Nagavci B, et al. ERS/ESICM/ESCMID/ALAT guidelines for the management of severe community-acquired pneumonia. Intensive Care Med. 2023. PMID: 37012484. doi:10.1007/s00134-023-07033-8
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。